Reply to correspondence on “Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction” Cho-Rong Lee, Sung-Gyoo Park Clinical and Molecular Hepatology.2024; 30(4): 1053. CrossRef
Background/Aims The major histocompatibility class II (MHC II) transactivator, known as CIITA, is induced by Interferon gamma (IFN-γ) and plays a well-established role in regulating the expression of class II MHC molecules in antigen-presenting cells.
Methods Primary human hepatocytes (PHH) were isolated via therapeutic hepatectomy from two donors. The hepatocellular carcinoma (HCC) cell lines HepG2 and Huh7 were used for the mechanistic study, and HBV infection was performed in HepG2-NTCP cells. HBV DNA replication intermediates and secreted antigen levels were measured using Southern blotting and ELISA, respectively.
Results We identified a non-canonical function of CIITA in the inhibition of hepatitis B virus (HBV) replication in both HCC cells and patient-derived PHH. Notably, in vivo experiments demonstrated that HBV DNA and secreted antigen levels were significantly decreased in mice injected with the CIITA construct. Mechanistically, CIITA inhibited HBV transcription and replication by suppressing the activity of HBV-specific enhancers/promoters. Indeed, CIITA exerts antiviral activity in hepatocytes through ERK1/2-mediated down-regulation of the expression of hepatocyte nuclear factor 1α (HNF1α) and HNF4α, which are essential factors for virus replication. In addition, silencing of CIITA significantly abolished the IFN-γ-mediated anti-HBV activity, suggesting that CIITA mediates the anti-HBV activity of IFN-γ to some extent. HBV X protein (HBx) counteracts the antiviral activity of CIITA via direct binding and impairing its function.
Conclusions Our findings reveal a novel antiviral mechanism of CIITA that involves the modulation of the ERK pathway to restrict HBV transcription. Additionally, our results suggest the possibility of a new immune avoidance mechanism involving HBx.
Citations
Citations to this article as recorded by
The Role of CD4+ T Helper Cell Subsets in Hepatocellular Carcinoma: Implications for Tumour Progression and Immunotherapy Jijie Shao, Jintong Na, Honghua Huang, Lei Xiao, Fengqiu Dang, Rongshun Zheng, Liping Zhong, Yongxiang Zhao Cells.2026; 15(4): 350. CrossRef
DPP4 inhibition affects metabolism and inflammation associated pathways in hiPSC-derived steatotic HLCs Christiane Loerch, Wasco Wruck, Annika Wittich, Rabea Hokamp, Julian Reiss, Ole Pless, James Adjaye, Nina Graffmann Frontiers in Cell and Developmental Biology.2026;[Epub] CrossRef
Cytotoxic CD4+ T cells: origin, biological functions, diseases and therapeutic targets Longyong Lai, Shuan Ran, Yuan Li, Jikai Cui, Xi Zhang, Jizhang Yu, Yanqiang Zou, Cheng Zhou, Jiahong Xia, Jie Wu Signal Transduction and Targeted Therapy.2026;[Epub] CrossRef
IFI35 suppresses the transcription of hepatitis B virus cccDNA minichromosome via promoting HNF4α proteasomal degradation Nayeon Kim, Jae Jin Shin, Jae Won Oh, Juhee Won, Ah Ram Lee, Mehrangiz Dezhbord, Jeongwoo Park, Ki-Young Lee, Dong-Sik Kim, Kwang Pyo Kim, Kyun-Hwan Kim Journal of Biomedical Science.2026;[Epub] CrossRef
Impact of VHSV on CIITA-mediated MHCII expression and antigen presentation in largemouth bass Xiaobing Lu, Ziling Qin, Zhe Hu, Hao Huang, Jie Su, Xiaoru Zhang, Meisheng Yi, Kuntong Jia Fish & Shellfish Immunology.2025; 162: 110336. CrossRef
Viral oncogenesis in cancer: from mechanisms to therapeutics Qing Xiao, Yi Liu, Tingting Li, Chaoyu Wang, Sanxiu He, Liuyue Zhai, Zailin Yang, Xiaomei Zhang, Yongzhong Wu, Yao Liu Signal Transduction and Targeted Therapy.2025;[Epub] CrossRef
Bioinformatics and system biology approach to discover the common pathogenetic processes between COVID-19 and chronic hepatitis B Xiao Ma, Tengda Huang, Yujia Song, Hongyuan Pan, Ao Du, Xinyi Zhou, Yong Zeng, Kefei Yuan, Xiaosheng Tan PLOS One.2025; 20(5): e0323708. CrossRef
Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells Enis Kostallari, Robert F. Schwabe, Adrien Guillot Cellular & Molecular Immunology.2025; 22(10): 1205. CrossRef
Gender-specific alteration of steroid metabolism and its impact on viral replication in a mouse model of hepatitis B virus infection Eun-Sook Park, Juhee Won, Sung Hyun Ahn, Ah Ram Lee, Donghyo Lee, Ju-Yeon Moon, Man Ho Choi, Kyun-Hwan Kim Animal Cells and Systems.2024; 28(1): 466. CrossRef
Class II transactivator restricts viral replication, extending its effect to HBV: Editorial on “Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction” Cho-Rong Lee, Sung-Gyoo Park Clinical and Molecular Hepatology.2024; 30(4): 724. CrossRef
Chronic Hepatitis B Genotype C Mouse Model with Persistent Covalently Closed Circular DNA Deok-Hwa Seo, Wonhee Hur, Juhee Won, Ji-Won Han, Seung-Kew Yoon, Songmee Bae, Kyun-Hwan Kim, Pil-Soo Sung Viruses.2024; 16(12): 1890. CrossRef
First
Prev
